Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
Recent developments and advances of FGFR as a potential target in cancer
Wen-Jun Xue1, Ming-Tao Li1, Lin Chen1
1Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, PR China.
Abstract:
FGFs and their receptors (FGFRs) are critical for many biologic processes, including angiogenesis, wound healing and tissue regeneration. Aberrations in FGFR signaling are common in cancer, making FGFRs a promising target in antitumor studies. To date, many FGFR inhibitors are being detected in clinical studies, and resistance to some inhibitors has emerged. Understanding the mechanisms of resistance is a fundamental step for further implementation of targeted therapies. In this review, we will describe the basic knowledge regarding FGF/FGFR signaling and categorize the clinical FGFR inhibitors. The mechanisms of resistance to FGFR inhibitors and corresponding strategies of overcoming drug resistance will also be discussed.
Insights
Fibroblast Growth Factors (FGFs) and their receptors (FGFRs) are key in healing and regeneration. This review covers FGF/FGFR signaling, inhibitors, and strategies to overcome cancer drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Fibroblast Growth Factors (FGFs) and their receptors (FGFRs) are crucial for biological processes like angiogenesis, wound healing, and tissue regeneration.
- Dysregulation of FGFR signaling is frequently observed in various cancers, positioning FGFRs as significant therapeutic targets for antitumor strategies.
Purpose of the Study:
- To provide a comprehensive overview of FGF/FGFR signaling pathways.
- To categorize currently available clinical FGFR inhibitors.
- To elucidate mechanisms of resistance to FGFR inhibitors and discuss strategies to overcome this drug resistance.
Main Methods:
- Literature review of FGF/FGFR signaling.
- Analysis of clinical FGFR inhibitors.
- Discussion of resistance mechanisms and counter-strategies.
Main Results:
- FGFRs play a vital role in normal biological functions and cancer development.
- Several FGFR inhibitors are under clinical investigation for cancer treatment.
- Emergence of resistance to FGFR inhibitors necessitates understanding underlying mechanisms.
Conclusions:
- Targeted therapies inhibiting FGFR signaling hold promise for cancer treatment.
- Understanding and overcoming resistance mechanisms are critical for the effective clinical implementation of FGFR inhibitors.
- Further research into resistance pathways will guide the development of more effective antitumor strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Extraction: Advanced Methods
Standard Electrode Potentials
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...

